MedTrace Logo

Stroke Research Consortium in Northern Bavaria (STAMINA)

NCT04357899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3769

Last updated 2022-08-02

No results posted yet for this study

Summary

Each year, approximately 15 million people suffer a stroke worldwide of which 80% are due to ischemic cerebral infarction. Based on the results of randomized controlled trials, treatment options and patient outcomes in acute ischemic stroke have dramatically improved in recent years. However, these advances in thrombolysis and endovascular therapy need to be established outside controlled trials to optimize stroke management, treatment procedures, patient selection and inter-hospital transfer in clinical practice. This multicenter longitudinal cohort study is based on a large stroke care network in Northern Bavaria, Germany (region of more than 3.5 million inhabitants) to evaluate and improve treatment in ischemic stroke.

Conditions

Interventions

DRUG

thrombolysis therapy

PROCEDURE

endovascular therapy

PROCEDURE

decompressive surgery

DIAGNOSTIC_TEST

multimodal imaging in acute ischemic stroke

PROCEDURE

transfer of acute stroke patients to tertiary stroke centers

DRUG

initiation of antiplatelets, oral anticoagulation and lipid lowering drugs for secondary prevention

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Stefan Schwab · Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Department of Neurology, Germany

  • Arnd Dörfler · Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Department of Neuroradiology, Germany

  • Bernd Kallmünzer · Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Department of Neurology, Germany

  • Tobias Engelhorn · Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Department of Neuroradiology, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2019-12-31
Completion
2020-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04357899 on ClinicalTrials.gov